Genetic risk for inflammatory bowel disease is a determinant of Crohn's disease development in chronic granulomatous disease

Inflammatory Bowel Diseases

Volumn 22, Issue 12, 2016, Pages 2794-2801

  Huang, Chengrui ^a   De Ravin, Suk S ^b   Paul, Adam R ^c,d   Heller, Theo ^e   Ho, Nancy ^e   Wu Datta, Lisa ^d   Zerbe, Christa S ^b   Marciano, Beatriz E ^b   Kuhns, Douglas B ^f   Kader, Howard A ^c   Holland, Steven M ^b   Malech, Harry L ^b   Brant, Steven R ^a,d  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^f FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

Author keywords

chronic granulomatous disease; genetic interaction; genetic risk score; immunodeficiency disorder; inflammatory bowel disease

Indexed keywords

BIOLOGICAL MARKER; CXCL14 CHEMOKINE; LACCASE DOMAIN CONTAINING 1 PROTEIN; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL GROWTH INHIBITOR; LACC1 PROTEIN, HUMAN; PROTEIN; TNFSF15 PROTEIN, HUMAN;

ARTICLE; CAUCASIAN; CHRONIC GRANULOMATOUS DISEASE; CONTROLLED STUDY; CROHN DISEASE; EUROPEAN; FEMALE; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ADOLESCENT; ALLELE; CHILD; COMPLICATION; EVALUATION STUDY; GENETIC PREDISPOSITION; GENETICS; PRESCHOOL CHILD; RISK FACTOR;

ADOLESCENT; ALLELES; CHILD; CHILD, PRESCHOOL; CROHN DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; RISK FACTORS; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 15;

EID: 84994667671     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000966     Document Type: Article

References (27)

1. Winkelstein JA, Marino MC, Johnston RB, Jr, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine. 2000; 79: 155-169
2. Segal BH, Leto TL, Gallin JI, et al. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine. 2000; 79: 170-200
3. Matute JD, Arias AA, Wright NA, et al. A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity. Blood. 2009; 114: 3309-3315
4. Marciano BE, Wesley R, De Carlo ES, et al. Long-term interferon-gamma therapy for patients with chronic granulomatous disease. Clin Infect Dis. 2004; 39: 692-699
5. Gallin JI, Alling DW, Malech HL, et al. Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med. 2003; 348: 2416-2422
6. Gungor T, Halter J, Klink A, et al. Successful low toxicity hematopoietic stem cell transplantation for high-risk adult chronic granulomatous disease patients. Transplantation. 2005; 79: 1596-1606
7. Gungor T, Teira P, Slatter M, et al. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study. Lancet. 2014; 383: 436-448
8. Marciano BE, Rosenzweig SD, Kleiner DE, et al. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics. 2004; 114: 462-468
9. Marks DJ, Miyagi K, Rahman FZ, et al. Inflammatory bowel disease in CGD reproduces the clinicopathological features of Crohn's disease. Am J Gastroenterol. 2009; 104: 117-124
10. Kugathasan S, Judd RH, Hoffmann RG, et al. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. J Pediatr. 2003; 143: 525-531
11. Jones LB, McGrogan P, Flood TJ, et al. Special article: Chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry. Clin Exp Immunol. 2008; 152: 211-218
12. Dassopoulos T, Nguyen GC, Bitton A, et al. Assessment of reliability and validity of IBD phenotyping within the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) IBD Genetics Consortium (IBDGC). Inflamm Bowel Dis. 2007; 13: 975-983
13. Uzel G, Orange JS, Poliak N, et al. Complications of tumor necrosis factor-alpha blockade in chronic granulomatous disease-related colitis. Clin Infect Dis. 2010; 51: 1429-1434
14. Stone MA, Mayberry JF, Baker R. Prevalence and management of inflammatory bowel disease: a cross-sectional study from central England. Eur J Gastroenterol Hepatol. 2003; 15: 1275-1280
15. Liu JZ, Van Sommeren S, Huang H, et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet. 2015; 47: 979-986
16. Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012; 491: 119-124
17. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for wholegenome association and population-based linkage analyses. Am J Hum Genet. 2007; 81: 559-575
18. Clayton D. Version R Package Version 1.6.0. 2012
19. Jostins L, Levine AP, Barrett JC. Using genetic prediction from known complex disease Loci to guide the design of next-generation sequencing experiments. PLoS One. 2013; 8: e76328
20. Alimchandani M, Lai JP, Aung PP, et al. Gastrointestinal histopathology in chronic granulomatous disease: a study of 87 patients. Am J Surg Pathol. 2013; 37: 1365-1372
21. Podolsky DK. Inflammatory bowel disease.N. Engl. J. Med. 2002; 347: 417-429
22. Foster CB, Lehrnbecher T, Mol F, et al. Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease. J Clin Invest. 1998; 102: 2146-2155
23. Assadi G, Saleh R, Hadizadeh F, et al. LACC1 polymorphisms in inflammatory bowel disease and juvenile idiopathic arthritis. Genes Immun. 2016; 17: 261-264
24. Joo SS, Lee DI, Hwang KW. Inhibition of cytokine-induced beta cell apoptosis via laccase and its therapeutic advantages for insulindependent diabetes mellitus, type 1 diabetes. Biol Pharm Bull. 2010; 33: 1854-1860
25. Cho JH, Brant SR. Recent insights into the genetics of inflammatory bowel disease. Gastroenterology. 2011; 140: 1704-1712
26. Prehn JL, Mehdizadeh S, Landers CJ, et al. Potential role for TL1A, the new TNF-family member and potent costimulator of IFN-gamma, in mucosal inflammation. Clin Immunol. 2004; 112: 66-77
27. Lazarev M, Huang C, Bitton A, et al. Relationship between proximal Crohn's disease location and disease behavior and surgery: a crosssectional study of the IBD Genetics Consortium. Am J Gastroenterol. 2013; 108: 106-112